← Back to PLSE

Pulse Biosciences, Inc - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 05/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 05/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 08/05/2025
$0.4$0.4$0.1$0$0$0$0$0
−$25−$19−$19−$19−$17−$13−$11−$10
−$0.36−$0.27−$0.29−$0.28−$0.25−$0.21−$0.20−$0.18
6968676767615757

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.